Literature DB >> 21054896

Comparison between amniotomy, oxytocin or both for augmentation of labor in prolonged latent phase: a randomized controlled trial.

Zohar Nachum1, Gali Garmi, Yfat Kadan, Noah Zafran, Eliezer Shalev, Raed Salim.   

Abstract

BACKGROUND: A prolonged latent phase is independently associated with an increased incidence of subsequent labor abnormalities. We aimed to compare between oxytocin augmentation, amniotomy and a combination of both on the duration of labor among women with a prolonged latent phase.
METHODS: Women with a singleton fetus in cephalic presentation who have a prolonged latent phase, were randomly allocated to amniotomy (group 1), oxytocin (group 2) or both (group 3). A group of women who progressed spontaneously without intervention composed the control group (group 4). The primary outcome was the duration of time from initiation of augmentation until delivery.
RESULTS: A total of 213 women were consented and randomized to group 1 (70 women), group 2 (72 women) and group 3 (71 women). Group 4 was composed from additional 70 women. A mean reduction of 120 minutes in labor duration was observed among group 3 compared to group 1 (p = 0.08) and 180 minutes compared to group 2 and 4 (p = 0.001). Women in group 3 had a shorter length of time from augmentation until the beginning of the active phase and a shorter first stage of labor than group 1 (p = 0.03), group 2 (p = 0.001) and group 4 (p = 0.001). Satisfaction was greater among group 3 and 4. Mode of delivery and neonatal outcome were comparable between the groups.
CONCLUSION: Labor augmentation by combined amniotomy and oxytocin among women with a prolonged latent phase at term seems superior compared to either of them alone.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21054896      PMCID: PMC2988803          DOI: 10.1186/1477-7827-8-136

Source DB:  PubMed          Journal:  Reprod Biol Endocrinol        ISSN: 1477-7827            Impact factor:   5.211


  22 in total

1.  Maternal and fetal risks associated with prolonged latent phase of labour.

Authors:  J Maghoma; E J Buchmann
Journal:  J Obstet Gynaecol       Date:  2002-01       Impact factor: 1.246

2.  An objective approach to the diagnosis and management of abnormal labor.

Authors:  E A Friedman
Journal:  Bull N Y Acad Med       Date:  1972-07

3.  The MFMU Cesarean Registry: impact of fetal size on trial of labor success for patients with previous cesarean for dystocia.

Authors:  Alan M Peaceman; Rebecca Gersnoviez; Mark B Landon; Catherine Y Spong; Kenneth J Leveno; Michael W Varner; Dwight J Rouse; Atef H Moawad; Steve N Caritis; Margaret Harper; Ronald J Wapner; Yoram Sorokin; Menachem Miodovnik; Marshall Carpenter; Mary J O'Sullivan; Baha M Sibai; Oded Langer; John M Thorp; Susan M Ramin; Brian M Mercer
Journal:  Am J Obstet Gynecol       Date:  2006-10       Impact factor: 8.661

Review 4.  Oxytocin: new perspectives on an old drug.

Authors:  Steven L Clark; Kathleen Rice Simpson; G Eric Knox; Thomas J Garite
Journal:  Am J Obstet Gynecol       Date:  2008-07-29       Impact factor: 8.661

5.  The association between the length of first stage of labor, mode of delivery, and perinatal outcomes in women undergoing induction of labor.

Authors:  Yvonne W Cheng; Shani S Delaney; Linda M Hopkins; Aaron B Caughey
Journal:  Am J Obstet Gynecol       Date:  2009-07-15       Impact factor: 8.661

Review 6.  The effect of early oxytocin augmentation in labor: a meta-analysis.

Authors:  Shu-Qin Wei; Zhong-Cheng Luo; Hairong Xu; William D Fraser
Journal:  Obstet Gynecol       Date:  2009-09       Impact factor: 7.661

7.  Some Swedish women's experiences of prolonged labour.

Authors:  Astrid Nystedt; Ulf Högberg; Berit Lundman
Journal:  Midwifery       Date:  2006-03       Impact factor: 2.372

8.  High and low dose oxytocin in augmentation of labor.

Authors:  A Jamal; R Kalantari
Journal:  Int J Gynaecol Obstet       Date:  2004-10       Impact factor: 3.561

9.  A negative birth experience: prevalence and risk factors in a national sample.

Authors:  Ulla Waldenström; Ingegerd Hildingsson; Christine Rubertsson; Ingela Rådestad
Journal:  Birth       Date:  2004-03       Impact factor: 3.689

10.  Early versus delayed oxytocin augmentation in nulliparous women with prolonged labour--a randomised controlled trial.

Authors:  A Dencker; M Berg; L Bergqvist; L Ladfors; L S Thorsén; H Lilja
Journal:  BJOG       Date:  2009-03       Impact factor: 6.531

View more
  6 in total

Review 1.  Early amniotomy and early oxytocin for prevention of, or therapy for, delay in first stage spontaneous labour compared with routine care.

Authors:  Shuqin Wei; Bi Lan Wo; Hui-Ping Qi; Hairong Xu; Zhong-Cheng Luo; Chantal Roy; William D Fraser
Journal:  Cochrane Database Syst Rev       Date:  2012-09-12

2.  Proactive versus standard support of labour in nulliparous women; study protocol for a randomized, controlled trial.

Authors:  Møyfrid Brenne Fehn; Raija Dahlø; Renate Nielsen; Ingebjørg Laache; Eszter Vanky
Journal:  Trials       Date:  2020-04-23       Impact factor: 2.279

3.  Frequency and determinants of misuse of augmentation of labor in France: A population-based study.

Authors:  Aude Girault; Béatrice Blondel; François Goffinet; Camille Le Ray
Journal:  PLoS One       Date:  2021-02-09       Impact factor: 3.240

4.  Labour management and Obstetric outcomes among pregnant women admitted in latent phase compared to active phase of labour at Bugando Medical Centre in Tanzania.

Authors:  Clotrida Chuma; Albert Kihunrwa; Dismas Matovelo; Marietha Mahendeka
Journal:  BMC Pregnancy Childbirth       Date:  2014-02-12       Impact factor: 3.007

5.  Induction of labor compared to expectant management in term nulliparas with a latent phase of labor of more than 8 hours: a randomized trial.

Authors:  Patrick Naveen Sargunam; Lindy Li Mei Bak; Peng Chiong Tan; Narayanan Vallikkannu; Mat Adenan Noor Azmi; Syeda Nureena Zaidi; Sandar Tin Win; Siti Zawiah Omar
Journal:  BMC Pregnancy Childbirth       Date:  2019-12-11       Impact factor: 3.007

6.  Reducing neonatal morbidity by discontinuing oxytocin during the active phase of first stage of labor: a multicenter randomized controlled trial STOPOXY.

Authors:  Aude Girault; François Goffinet; Camille Le Ray
Journal:  BMC Pregnancy Childbirth       Date:  2020-10-20       Impact factor: 3.007

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.